These results suggest that the mRNA expression of the EYA1/3/4 gene is significantly correlated with the prognosis of ccRCC patients and therefore can be used as a better biomarker to predict the survival time of ccRCC. Here, EYA1 is linked to nonpapillary renal cell carcinoma.